Sarah Shultz, a biomechanist and the dean of the School of Health Sciences at the University of New Haven, surmised to ESPN that GLP-1 drugs could have substantial benefits for athletes like Williams, noting that "when you have both weight loss and a change in inflammation, which is what the hormone's going to do for you, then you're going to lose that joint pain" and "when you think about it in terms of blood sugar, if her blood sugar is being regulated in a way that it wasn't previously, which is what the drug is supposed to do, now fatigue isn't as big of a deal either, and recovery is easier." Only time will tell if GLP-1 meds eventually become classified as a banned performance-enhancing drug
When these details line up, the experience feels polished instead of pushy, letting you switch from reels to live-action tables without stutters or unexpected pop-ups
[2] Pikal, M
Human studies need to be more robust to be able to comment on the safety of the long-term use of these peptides
peptide vendors in 2026: testing methodology, catalog depth, available formats, pricing, and how it compares against other domestic suppliers